Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up

Ragni, 1999, von Willebrand disease and bleeding in women, Haemophilia, 5, 313, 10.1046/j.1365-2516.1999.00342.x

Kadir, 1999, Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders, Haemophilia, 5, 40, 10.1046/j.1365-2516.1999.00285.x

Kouides, 2000, Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey, Haemophilia, 6, 643, 10.1046/j.1365-2516.2000.00447.x

James, 2005, More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders, Haemophilia, 11, 295, 10.1111/j.1365-2516.2005.01108.x

Lukes, 2005, Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact, Fertil Steril, 84, 1338, 10.1016/j.fertnstert.2005.04.061

Kadir, 1998, Quality of life during menstruation in patients with inherited bleeding disorders, Haemophilia, 4, 836, 10.1046/j.1365-2516.1998.00208.x

Stewart, 2001, The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review, BJOG, 108, 74, 10.1016/S0306-5456(00)00020-6

Varma, 2006, Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—a systematic enquiry and overview, Eur J Obstet Gynecol Reprod Biol, 125, 9, 10.1016/j.ejogrb.2005.10.029

Kingman, 2004, The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders, BJOG, 111, 1425, 10.1111/j.1471-0528.2004.00305.x

Schaedel, 2005, The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders, Am J Obstet Gynecol, 193, 1361, 10.1016/j.ajog.2005.05.002

Lukes, 2008, Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders, Fertil Steril, 90, 673, 10.1016/j.fertnstert.2007.07.1315

Kouides, 2006, The efficacy and safety of the levonorgestrel intrauterine device (Mirena) for bleeding disorder-related menorrhagia in an American cohort, Haemophilia, 12, 146

Higham, 1990, Assessment of menstrual blood loss using a pictorial chart, Br J Obstet Gynaecol, 97, 734, 10.1111/j.1471-0528.1990.tb16249.x

Lukes, 2005, von Willebrand's disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system, Obstet Gynecol, 105, 1223, 10.1097/01.AOG.0000157758.94890.59

Jones, 2000, Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery, Hum Reprod, 15, S162, 10.1093/humrep/15.suppl_3.162

Ibraheim, 2005, An evaluation of troublesome inter-menstrual bleeding in menorrhagic users of the LNG-IUS, J Obstet Gynaecol, 25, 384, 10.1080/01443610500134340

Hidalgo, 2002, Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years, Contraception, 65, 129, 10.1016/S0010-7824(01)00302-X

Backman, 2002, Advance information improves user satisfaction with the levonorgestrel intrauterine system, Obstet Gynecol, 99, 608, 10.1016/S0029-7844(01)01764-1

Backman, 2004, Benefit–risk assessment of the levonorgestrel intrauterine system in contraception, Drug Saf, 27, 1185, 10.2165/00002018-200427150-00003

Xiao, 2003, Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia, Fertil Steril, 79, 963, 10.1016/S0015-0282(02)04913-0

Inki, 2002, Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy, Ultrasound Obstet Gynecol, 20, 381, 10.1046/j.1469-0705.2002.00805.x

Jarvela, 1998, The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women, Hum Reprod, 13, 3379, 10.1093/humrep/13.12.3379